These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 14585336

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication.
    Wessely R, Klingel K, Knowlton KU, Kandolf R.
    Circulation; 2001 Feb 06; 103(5):756-61. PubMed ID: 11156890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL.
    J Virol; 2001 Mar 06; 75(5):2377-87. PubMed ID: 11160741
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice.
    Shim SH, Park JH, Ye MB, Nam JH.
    Acta Virol; 2013 Mar 06; 57(4):462-6. PubMed ID: 24294962
    [Abstract] [Full Text] [Related]

  • 11. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M, Yan K, Wei L, Yang J, Lu C, Xiong F, Zheng C, Xu W.
    Antiviral Res; 2015 Nov 06; 123():50-61. PubMed ID: 26343012
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sex Hormone Contributes to Sexually Dimorphic Susceptibility in CVB3-Induced Viral Myocarditis via Modulating IFN-γ+ NK Cell Production.
    Zhou N, Yue Y, Xiong S.
    Can J Cardiol; 2018 Apr 06; 34(4):492-501. PubMed ID: 29455951
    [Abstract] [Full Text] [Related]

  • 16. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
    Huber S, Shi C, Budd RC.
    J Virol; 2002 Jul 06; 76(13):6487-94. PubMed ID: 12050361
    [Abstract] [Full Text] [Related]

  • 17. [Effect and mechanism of Astragalus membranaceus on coxsackie B3 virus RNA in mice].
    Peng TQ, Yang YZ, Kandolf R.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Nov 06; 14(11):664-6. PubMed ID: 7703635
    [Abstract] [Full Text] [Related]

  • 18. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.
    Saraste A, Arola A, Vuorinen T, Kytö V, Kallajoki M, Pulkki K, Voipio-Pulkki LM, Hyypiä T.
    Cardiovasc Pathol; 2003 Nov 06; 12(5):255-62. PubMed ID: 14507574
    [Abstract] [Full Text] [Related]

  • 19. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y, Zhu R, Luo L, Mu Q, Zhu Y, Luo H, Zou X, Shen X.
    Intervirology; 2015 Nov 06; 58(6):343-9. PubMed ID: 26829552
    [Abstract] [Full Text] [Related]

  • 20. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
    Cai Z, Shen L, Ma H, Yang J, Yang D, Chen H, Wei J, Lu Q, Wang DW, Xiang M, Wang J.
    Circ Heart Fail; 2015 Jul 06; 8(4):809-18. PubMed ID: 25985795
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.